C07D 271/06
1,2,4-oxadiazoles
Official title: 1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
C07D271/06 (1,2,4-oxadiazoles) appears on 1,187 US grants and 1,251 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,187
- Published applications
- 1,251
- Assignees
- 553
- Inventors
- 3,992
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 13 | 0 |
| 1977 | 3 | 0 |
| 1978 | 8 | 0 |
| 1979 | 12 | 0 |
| 1980 | 7 | 0 |
| 1981 | 7 | 0 |
| 1982 | 12 | 0 |
| 1983 | 15 | 0 |
| 1984 | 10 | 0 |
| 1985 | 8 | 0 |
| 1986 | 6 | 0 |
| 1987 | 9 | 0 |
| 1988 | 10 | 0 |
| 1989 | 8 | 0 |
| 1990 | 14 | 0 |
| 1991 | 9 | 0 |
| 1992 | 10 | 0 |
| 1993 | 16 | 0 |
| 1994 | 14 | 0 |
| 1995 | 12 | 0 |
| 1996 | 16 | 0 |
| 1997 | 21 | 0 |
| 1998 | 17 | 0 |
| 1999 | 30 | 0 |
| 2000 | 17 | 0 |
| 2001 | 26 | 6 |
| 2002 | 30 | 34 |
| 2003 | 33 | 49 |
| 2004 | 21 | 62 |
| 2005 | 31 | 57 |
| 2006 | 36 | 45 |
| 2007 | 27 | 41 |
| 2008 | 22 | 44 |
| 2009 | 25 | 64 |
| 2010 | 36 | 61 |
| 2011 | 37 | 43 |
| 2012 | 33 | 48 |
| 2013 | 37 | 43 |
| 2014 | 55 | 67 |
| 2015 | 35 | 46 |
| 2016 | 45 | 35 |
| 2017 | 36 | 53 |
| 2018 | 42 | 59 |
| 2019 | 33 | 55 |
| 2020 | 38 | 71 |
| 2021 | 41 | 60 |
| 2022 | 39 | 49 |
| 2023 | 29 | 62 |
| 2024 | 46 | 45 |
| 2025 | 27 | 34 |
| 2026 | 23 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Fungicidal composition containing oxadiazole compounds28 Jul 2026US 12,690,591 B2Pi Industries Ltd.
- Use of caseinolytic protease P function as a biomarker of drug response to imipridone-like agents28 Jul 2026US 12,692,267 B2Madera Therapeutics, LLC
- Oxadiazole compounds for controlling or preventing phytopathogenic fungi14 Jul 2026US 12,677,832 B2Pi Industries Ltd.
- Preparation of substituted aromatic carboxamides16 Jun 2026US 12,655,117 B2BASF SE
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications1 Oct 2026US 2026/0297012 A1NucMito Pharmaceuticals Co. Ltd.
- Err modulators17 Sep 2026US 2026/0274807 A1University of Health Sciences & Pharmacy in St. Louis
- Oxadiazole derivative20 Aug 2026US 2026/0242345 A1Sumitomo Pharma Co., Ltd.
- Amide compounds or salts thereof, bactericidal agents for agriculture and horticulture containing said compounds, and method of using same23 Jul 2026US 2026/0206763 A1Nihon Nohyaku Co., Ltd.
- Preparation of 4-cyanobenzoyl chlorides from alkali metal 4-carbamoyl-benzoates16 Jul 2026US 2026/0200832 A1BASF SE
Most cited
By later US patents
- Compounds and compositions for intracellular delivery of therapeutic agents143US 9,868,691 B2ModernaTX, Inc. · 2018
- 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease102US 6,992,096 B2PTC Therapeutics, Inc. · 2006
- Heterocyclic-substituted alkyl amide acat inhibitors83US 5,693,657 AWarner-Lambert Company · 1997
- Inhibitors of IMPDH enzyme technical field of the invention73US 6,653,309 B1Vertex Pharmaceuticals Incorporated · 2003
- Cyclic amine derivatives and their use as drugs67US 6,362,177 B1DuPont Pharmaceuticals Research Laboratories, Inc. · 2002